Spots Global Cancer Trial Database for A Clinical Study of T3011 in Subjects With Advanced Melanoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Clinical Study of T3011 in Subjects With Advanced Melanoma
Official Title: A Phase Ib/IIa Clinical Study to Evaluate the Tolerability, Safety and Preliminary Efficacy of T3011 in Subjects With Advanced Melanoma
Study ID: NCT06214156
Conditions
Interventions
Study Description
Brief Summary: This clinical study evaluated the tolerability, safety and preliminary efficacy of T3011 in subjects with advanced melanoma.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Beijing Cancer Hospital, Beijing, , China
The First Affiliated Hospital of Bengbu Medical College, Bengbu, , China
Jilin Cancer Hospital, Changchun, , China
Chengdu Shangjin Nanfu Hospital, Chengdu, , China
Fujian Cancer Hospital, Fuzhou, , China
The Third People's Hospital of Zhengzhou, Zhengzhou, , China
Sun Yat-sen University Cancer Center, Zhongshan, , China
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
